RNA Biology
Volume 21, 2024 - Issue 1
Open access
95
Views
0
CrossRef citations to date
0
Altmetric
Research Paper
Silencing LINC00663 inhibits inflammation and angiogenesis through downregulation of NR2F1 via EBF1 in bladder cancer
Xiulong Zhonga Department of Urology Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, P.R. ChinaView further author information
, Lijiang Suna Department of Urology Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, P.R. ChinaView further author information
, Junxiang Liua Department of Urology Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, P.R. ChinaView further author information
, Xiaokun Yanga Department of Urology Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, P.R. ChinaView further author information
, Minghui Houa Department of Urology Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, P.R. ChinaView further author information
, Xinning Wangb Medical Record Management Center, Affiliated Hospital of Qingdao University, Qingdao, Shandong, P.R. ChinaView further author information
& Huifeng Diaoa Department of Urology Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, P.R. ChinaCorrespondence[email protected]
View further author information
show allView further author information
Pages 9-22
|
Accepted 11 Jun 2024, Published online: 18 Jun 2024
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.